2025 DCAT Summit at Lugano: Key Takeaways and Insights

In a five-article seriesDCAT Value Chain Insights provides highlights and perspectives from the DCAT Summit at Lugano: Expedition Pharma – Innovation from a Patient-First Perspective, held 4-5 June 2025, in Lugano, Switzerland.

The first article, Driving Value through Patient-Centricity in Drug Development and the Supply Chain, explores how expert speakers emphasized the ethical and economic imperative of putting patients first—and examined how the industry can more fully realize this all-important goal. Read more in the recap article.

The second article, Innovation at the Foundation of Pharmaceutical Development & Manufacturing, highlights how industry leaders are redefining speed, scalability, and sustainability at the very core of bio/pharmaceutical production. Read more in the recap article.

The third article, Serving Patients through Agility and Innovation in Development and Manufacturing, highlights how leaders from Eli Lilly & Company, Axplora, Made Scientific, and enGene emphasized the essential role of agility and innovation in accelerating complex therapies and designing treatments for real-world patient care. Read more in the recap article.

The fourth article, Innovating Formulation Development & Drug Delivery for Improving Patient Outcomes, highlights how industry leaders at the DCAT Summit in Lugano explored cutting-edge technologies—from nanoparticle engineering to needle-free delivery systems—that are reshaping patient-centric drug design and enhancing treatment outcomes. Read more in the recap article.

The fifth article, Trade, Global Manufacturing, Sustainability & AI Through a Patient’s Lens, examined macro issues impacting the industry today—tariff/trade policy, geographic dispersion of pharmaceutical manufacturing, sustainability, and digitalization—all considered through the lens of what is central to the industry: the patient. Read more in the recap article.

Thank you to our 2025 sponsors